Epidemiology of clinical benign prostatic hyperplasia

doi:10.1016/j.ajur.2017.06.004

Asian Journal of Urology, 2017, 4 (3): 148-151 doi: 10.1016/j.ajur.2017.06.004

Review

Current Issue | Archive | Adv Search

Epidemiology of clinical benign prostatic hyperplasia

Kok Bin Lim

Raffles Urology Centre, Raffles Hospital, Singapore

Abstract
Related Citation (15)

Download:

HTML

PDF (314KB)
Export: BibTeX | EndNote (RIS)

Abstract Clinical benign prostatic hyperplasia (BPH) is one of the most common diseases in ageing men and the most common cause of lower urinary tract symptoms (LUTS). The prevalence of BPH increases after the age of 40 years, with a prevalence of 8%-60% at age 90 years. Some data have suggested that there is decreased risk among the Asians compared to the western white population. Genetics, diet and life style may play a role here. Recent reports suggest the strong relationship of clinical BPH with metabolic syndrome and erectile dysfunction, as well as the possible role of inflammation as a cause of the prostatic hyperplasia. Lifestyle changes including exercise and diet are important strategies in controlling this common ailment.

Key words： Epidemiology Benign prostatic hyperplasia Ageing Lifestyle Physical activity Diet Inflammation

Received: 21 September 2016 Published: 26 August 2017

	Service
	E-mail this article
	Add to citation manager
	E-mail Alert
	Articles by authors
	Kok Bin Lim

TRENDMD:

Cite this article:

Kok Bin Lim. Epidemiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 148-151.

URL:

http://www.ajurology.com/EN/10.1016/j.ajur.2017.06.004 OR http://www.ajurology.com/EN/Y2017/V4/I3/148